{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T19:28:21Z","timestamp":1789241301287,"version":"build-2803163510"},"reference-count":43,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T00:00:00Z","timestamp":1663286400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec><jats:title>Purpose<\/jats:title><jats:p>Coagulation disorder in congestive heart failure (CHF) has been well-documented. The prognostic value of a composite coagulation disorder score, which combines the absolute platelet count, international normalized ratio (INR), and activated partial thromboplastin time (APTT), has not been assessed in CHF. The present study endeavored to explore the association between the coagulation disorder score and adverse outcomes of critically ill patients with CHF.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Patients diagnosed with CHF in the Medical Information Mart for Intensive Care III (MIMIC-III) database were included in the present retrospective cohort study. The coagulation disorder score was calculated according to the abnormalities of the absolute platelet count, INR, and APTT within 24 h after intensive care unit admission. The primary outcomes were the short-term all-cause mortality, including 30-, 90-day and in-hospital mortalities. The Kaplan\u2013Meier (K-M) survival curve and the Cox proportional hazard model were performed to assess the correlation between coagulation disorder score and outcome events.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 6,895 patients were enrolled in this study and divided into four groups according to the coagulation disorder score. K-M survival curve preliminarily indicated that subjects with higher coagulation disorder score presented lower survival rate and shorter survival time. After adjustment for potential confounders, the multivariate Cox analysis further illustrated that elevated coagulation disorder score as a quartile variable was significantly associated with increased all-cause mortality (quartile 4 vs. quartile 1, 30-day: HR [95% CI], 1.98 [1.50, 2.62], 90-day: HR [95% CI], 1.88 [1.49, 2.37], in-hospital: HR [95%CI], 1.93 [1.42, 2.61]).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>In critically ill patients with CHF, ones with high coagulation disorder score tend to be worse clinical prognosis, which would be a promising biomarker and helpful for the management of CHF patients.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcvm.2022.999391","type":"journal-article","created":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T12:27:13Z","timestamp":1663331233000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["A retrospective cohort study on the association between early coagulation disorder and short-term all-cause mortality of critically ill patients with congestive heart failure"],"prefix":"10.3389","volume":"9","author":[{"given":"Yiyang","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benhui","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baohua","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meijuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenghui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihuang","family":"Zha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaixin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,9,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"B2","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1001\/jamainternmed.2015.0924","article-title":"A contemporary appraisal of the heart failure epidemic in Olmsted County, Minnesota, 2000 to 2010","volume":"175","author":"Gerber","year":"2015","journal-title":"JAMA Intern Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.ejheart.2006.01.001","article-title":"Clinical profile, contemporary management and one-year mortality in patients with severe acute heart failure syndromes: the EFICA study","volume":"8","author":"Zannad","year":"2006","journal-title":"Eur J Heart Fail."},{"key":"B4","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.bpa.2017.07.003","article-title":"Long-term management of end-stage heart failure","volume":"31","author":"Habal","year":"2017","journal-title":"Best Pract Res Clin Anaesthesiol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1002\/ejhf.779","article-title":"Left ventricular assist device therapy in advanced heart failure: patient selection and outcomes","volume":"19","author":"Gustafsson","year":"2017","journal-title":"Eur J Heart Fail."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1002\/ejhf.1236","article-title":"Advanced heart failure: a position statement of the Heart Failure Association of the European Society of Cardiology","volume":"20","author":"Crespo-Leiro","year":"2018","journal-title":"Eur J Heart Fail."},{"key":"B7","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.jchf.2021.01.003","article-title":"Cardiopulmonary exercise testing-based risk stratification in the modern era of advanced heart failure management","volume":"9","author":"Lewis","year":"2021","journal-title":"JACC Heart Fail."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1161\/CIRCRESAHA.121.318158","article-title":"Mechanisms and models in heart failure: a translational approach","volume":"128","author":"Mann","year":"2021","journal-title":"Circ Res."},{"key":"B9","doi-asserted-by":"publisher","first-page":"746494","DOI":"10.3389\/fphys.2021.746494","article-title":"Inflammation in human heart failure: major mediators and therapeutic targets","volume":"12","author":"Reina-Couto","year":"2021","journal-title":"Front Physiol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.cardfail.2007.01.009","article-title":"The incidence of ischemic stroke in chronic heart failure: a meta-analysis","volume":"13","author":"Witt","year":"2007","journal-title":"J Card Fail."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.7150\/ijbs.7502","article-title":"The vascular endothelium and human diseases","volume":"9","author":"Rajendran","year":"2013","journal-title":"Int J Biol Sci."},{"key":"B12","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1007\/s10741-012-9352-9","article-title":"The immunological axis in heart failure: importance of the leukocyte differential","volume":"18","author":"Vaduganathan","year":"2013","journal-title":"Heart Fail Rev."},{"key":"B13","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s11897-016-0308-6","article-title":"Coagulation abnormalities in heart failure: pathophysiology and therapeutic implications","volume":"13","author":"Kim","year":"2016","journal-title":"Curr Heart Fail Rep."},{"key":"B14","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1253\/circj.CJ-15-1326","article-title":"Prognostic value of prothrombin time international normalized ratio in acute decompensated heart failure- a combined marker of hepatic insufficiency and hemostatic abnormality","volume":"80","author":"Okada","year":"2016","journal-title":"Circ J."},{"key":"B15","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1097\/MBC.0000000000000755","article-title":"Comparison of a new criteria for sepsis-induced coagulopathy and International Society on Thrombosis and Haemostasis disseminated intravascular coagulation score in critically ill patients with sepsis 3.0: a retrospective study","volume":"29","author":"Ding","year":"2018","journal-title":"Blood Coagul Fibrinolysis."},{"key":"B16","doi-asserted-by":"publisher","first-page":"e017046","DOI":"10.1136\/bmjopen-2017-017046","article-title":"New criteria for sepsis-induced coagulopathy (SIC) following the revised sepsis definition: a retrospective analysis of a nationwide survey","volume":"7","author":"Iba","year":"2017","journal-title":"BMJ Open."},{"key":"B17","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1055\/s-0038-1676610","article-title":"External validation of the two newly proposed criteria for assessing coagulopathy in sepsis","volume":"119","author":"Yamakawa","year":"2019","journal-title":"Thromb Haemost."},{"key":"B18","doi-asserted-by":"publisher","first-page":"724942","DOI":"10.3389\/fcvm.2021.724942","article-title":"Early coagulation disorder is associated with an increased risk of atrial fibrillation in septic patients","volume":"8","author":"Long","year":"2021","journal-title":"Front Cardiovasc Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1097\/ALN.0000000000003122","article-title":"Sepsis-induced coagulopathy and disseminated intravascular coagulation","volume":"132","author":"Iba","year":"2020","journal-title":"Anesthesiology."},{"key":"B20","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1007\/s00380-017-0946-y","article-title":"Prognostic impact of disseminated intravascular coagulation score in acute heart failure patients referred to a cardiac intensive care unit: a retrospective cohort study","volume":"32","author":"Itani","year":"2017","journal-title":"Heart Vessels."},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-022-10391-y.","article-title":"Heat-shock protein 90alpha is a potential prognostic and predictive biomarker in hepatocellular carcinoma: a large-scale and multicenter study","author":"Su","year":"2022","journal-title":"Hepatol Int."},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0000000000005450.","article-title":"Lymph node ratio improves prediction of overall survival in esophageal cancer patients receiving neoadjuvant chemoradiotherapy: a national cancer database analysis","author":"Zhang","year":"2022","journal-title":"Ann Surg."},{"key":"B23","doi-asserted-by":"publisher","first-page":"374","DOI":"10.5694\/mja2.50781","article-title":"Gut microbiota-derived trimethylamine N-oxide is associated with poor prognosis in patients with heart failure","volume":"213","author":"Li","year":"2020","journal-title":"Med J Aust."},{"key":"B24","doi-asserted-by":"publisher","first-page":"160035","DOI":"10.1038\/sdata.2016.35","article-title":"MIMIC-III, a freely accessible critical care database","volume":"3","author":"Johnson","year":"2016","journal-title":"Sci Data."},{"key":"B25","doi-asserted-by":"publisher","first-page":"g14","DOI":"10.1136\/bmj.g14","article-title":"First trimester fetal growth restriction and cardiovascular risk factors in school age children: population based cohort study","volume":"348","author":"Jaddoe","year":"2014","journal-title":"BMJ."},{"key":"B26","doi-asserted-by":"publisher","first-page":"172629","DOI":"10.1016\/j.ejphar.2019.172629","article-title":"Vasoactive intestinal peptide infusion reverses existing myocardial fibrosis in the rat","volume":"862","author":"Duggan","year":"2019","journal-title":"Eur J Pharmacol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1038\/nrcardio.2015.137","article-title":"New medical therapies for heart failure","volume":"12","author":"von Lueder","year":"2015","journal-title":"Nat Rev Cardiol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"812654","DOI":"10.3389\/fcvm.2022.812654","article-title":"Serum soluble ST2 is a valuable prognostic biomarker in patients with acute heart failure","volume":"9","author":"Wang","year":"2022","journal-title":"Front Cardiovasc Med."},{"key":"B29","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.cca.2014.10.023","article-title":"Multiple biomarker strategies for risk stratification in heart failure","volume":"443","author":"Bayes-Genis","year":"2015","journal-title":"Clin Chim Acta."},{"key":"B30","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.jchf.2016.12.016","article-title":"Meta-analysis of soluble suppression of tumorigenicity-2 and prognosis in acute heart failure","volume":"5","author":"Aimo","year":"2017","journal-title":"JACC Heart Fail."},{"key":"B31","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1097\/HCO.0000000000000596","article-title":"Biomarker developments in heart failure: 2016 and beyond","volume":"34","author":"Wettersten","year":"2019","journal-title":"Curr Opin Cardiol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"3455372","DOI":"10.1155\/2022\/3455372","article-title":"The value of SII in predicting the mortality of patients with heart failure","volume":"2022","author":"Yuan","year":"2022","journal-title":"Dis Markers."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1016\/j.ijcard.2012.12.018","article-title":"Is thrombosis a contributor to heart failure pathophysiology? Possible mechanisms, therapeutic opportunities, and clinical investigation challenges","volume":"167","author":"Zannad","year":"2013","journal-title":"Int J Cardiol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.jchf.2021.01.009","article-title":"Thromboembolism in heart failure patients in sinus rhythm: epidemiology, pathophysiology, clinical trials, and future direction","volume":"9","author":"Lin","year":"2021","journal-title":"JACC Heart Fail."},{"key":"B35","doi-asserted-by":"publisher","first-page":"33","DOI":"10.5853\/jos.2017.02810","article-title":"Heart failure as a risk factor for stroke","volume":"20","author":"Kim","year":"2018","journal-title":"J Stroke."},{"key":"B36","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/0002-8703(94)90670-X","article-title":"Relationship between hemostatic abnormalities and neuroendocrine activity in heart failure","volume":"127","author":"Sbarouni","year":"1994","journal-title":"Am Heart J."},{"key":"B37","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1111\/bjh.17172","article-title":"Disseminated intravascular coagulation: epidemiology, biomarkers, and management","volume":"192","author":"Adelborg","year":"2021","journal-title":"Br J Haematol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1001\/jama.2016.20328","article-title":"Prognostic accuracy of the SOFA score, SIRS criteria, and qSOFA score for in-hospital mortality among adults with suspected infection admitted to the intensive care unit","volume":"317","author":"Raith","year":"2017","journal-title":"JAMA."},{"key":"B39","doi-asserted-by":"publisher","first-page":"20802","DOI":"10.1038\/s41598-020-77967-2","article-title":"SOFA score and short-term mortality in acute decompensated heart failure","volume":"10","author":"Elias","year":"2020","journal-title":"Sci Rep."},{"key":"B40","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.cardfail.2021.10.006","article-title":"Sex differences in heart failure","volume":"28","author":"Lala","year":"2022","journal-title":"J Card Fail."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1056\/NEJMoa020265","article-title":"Long-term trends in the incidence of and survival with heart failure","volume":"347","author":"Levy","year":"2002","journal-title":"N Engl J Med."},{"key":"B42","doi-asserted-by":"publisher","first-page":"616273","DOI":"10.3389\/fcvm.2020.616273","article-title":"Sex influence on heart failure prognosis","volume":"7","author":"Postigo","year":"2020","journal-title":"Front Cardiovasc Med."},{"key":"B43","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1055\/s-0035-1564042","article-title":"Gender difference in efficacy and safety of nonvitamin k antagonist oral anticoagulants in patients with nonvalvular atrial fibrillation or venous thromboembolism: a systematic review and a meta-analysis of the literature","volume":"41","author":"Dentali","year":"2015","journal-title":"Semin Thromb Hemost."}],"updated-by":[{"DOI":"10.3389\/fcvm.2022.1116632","type":"corrigendum","label":"Corrigendum","source":"publisher","updated":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T00:00:00Z","timestamp":1671062400000}}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.999391\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T12:29:03Z","timestamp":1671107343000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.999391\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,16]]},"references-count":43,"alternative-id":["10.3389\/fcvm.2022.999391"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2022.999391","relation":{"corrigendum":[{"id-type":"doi","id":"10.3389\/fcvm.2022.1116632","asserted-by":"object"}]},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,16]]},"article-number":"999391"}}